drug
as of 2026-07-01Minocycline
minocyclineMinocycline Plus Omega-3 fatty acidsMinocycline 100mg
MeSH D008911
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Pakistan Institute of Living and Learning
15 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Neurobehavioral ManifestationsSchizophreniacyclopia sequenceInflammationNegative and Cognitive Symptoms in SchizophreniaPsychosisSchizophrenia Spectrum and Other Psychotic DisordersFirst Episode PsychosisSchizophreniform DisorderMental DisordersSchizophreniaAt Risk Mental State (ARMS)Tobacco UseTobacco UsePsychotic DisordersSchizoaffective Disorder
Trials
15
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia
NCT02533232Phase 1Unknown
Anti-inflammatories and Adolescent Schizophrenia
NCT04020588Phase 4Unknown
Minocycline and Tobacco Craving in Smokers With Schizophrenia
NCT02968602Phase 4Completed
Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States
NCT02569307Phase 2Completed
Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia
NCT02907437Phase 3Unknown
Minocycline Augmentation to Clozapine
NCT02124811Phase 4Completed
Minocycline for Schizophrenia
NCT01809158Phase 4Completed
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
NCT02928965Phase 2Completed
Minocycline Augmentation in Schizophrenia
NCT01561742—Unknown
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients
NCT01433055—Completed
Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study
NCT01133080Phase 4Unknown
Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder
NCT01320982Phase 3Unknown
The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia
NCT01493622Phase 4Completed
Role of Minocycline in First Episode Psychosis
NCT00916461Phase 1, Phase 2Completed
Minocycline for the Treatment of Early-Phase Schizophrenia
NCT00733057Phase 3Completed
KOLs & investigators
12
Mark Weiser, MDKOL score 9
Abebaw Fekadu, MD, PhDKOL score 6
Yechiel Levkovitz, MD, PhDKOL score 5
Dr.Inti Qurashi, MDKOL score 5
Rafael Octavio Stryjer, MDKOL score 5
Deanna L. Kelly, Pharm.D., BCPPKOL score 5
Nusrat Husain, MDKOL score 5
Prof Imran B Chaudhry, MDKOL score 5
Bill Deakin, ProfessorKOL score 4
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
trial
indication
indication
indication
indication
indication
KOL
Mark Weiser, MD
personKOL score 9
Abebaw Fekadu, MD, PhD
personKOL score 6
Yechiel Levkovitz, MD, PhD
personKOL score 5
Dr.Inti Qurashi, MD
personKOL score 5